Logo

Tell Congress to Fight Back Against a New Medicare Rule That Would Limit Access to Proton Therapy!

The Alliance for Proton Therapy Access is calling on Congress to oppose CMS Rule No. CMS-5527-P. Join us!

Tell Congress to Fight Back Against a New Medicare Rule That Would Limit Access to Proton Therapy!
The Center for Medicare and Medicaid Services (CMS) is proposing a new regulation that would drastically limit cancer patients’ access to proton therapy. If it moves forward, CMS’s alternative payment model would cut reimbursement for proton therapy to a rate that doesn’t come close to the cost of treatment. Providers will be forced to steer Medicare patients to less effective forms of treatment, many proton centers will lose revenue, some centers may close, and new centers won’t be built. The bottom line? Many fewer cancer patients will have access to this life-saving treatment.

CMS is arguing that the benefits of proton therapy are limited and not worth the extra costs. But as you know, thousands of cancer patients, survivors, and family members have seen first-hand the power of proton therapy to precisely target cancer cells, reduce side effects, and lower the risk of secondary cancer.

Now is the time to act! Please tell your members of Congress that CMS should not restrict access to proton therapy. Medicare beneficiaries and all cancer patients deserve fair access to treatment their doctors say will improve their chances of survival and preserve their quality of life.
    Subject
    Message Body
    Tweet
    Suggested Message
    Post
    Remaining: 0
  • Hide
    • Please call this number:

      Please do not close this window. You will need to come back to this window to enter your code.
      We just sent an email to ... containing a verification code.

      If you do not see the email within the next five minutes, please ensure you entered the correct email address and check your spam/junk mail folder.
      Enter Your Info
      Your Information
      Home Information

      Enter Your Info